In vitro conversion of normal prion protein into pathologic isoforms

Clinics in Laboratory Medicine

Volumn 23, Issue 1, 2003, Pages 227-247

  Bossers, Alex ^a   Rigter, Alan ^a   De Vries, Ruth ^a   Smits, Mari A ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ACCURACY; CELL CULTURE; CELL FREE SYSTEM; CONFORMATIONAL TRANSITION; HOST; HUMAN; INFECTION SENSITIVITY; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; REVIEW; SPECIES DIFFERENCE; VIRUS DETECTION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0037368744     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-2712(02)00063-X     Document Type: Review

References (101)

1. Griffith JS. Self-replication and scrapie. Nature 1967;215:1043-4.
2. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-44.
3. Vilette D, Andreoletti O, Archer F, et al. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci USA 2001;98:4055-9.
4. Kocisko DA, Come JH, Priola SA, et al. Cell-free formation of protease-resistant prion protein. Nature 1994;370:471-4.
5. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001;411:810-3.
6. Saborio GP, Soto C, Kascsak RJ, et al. Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone. Biochem Biophys Res Commun 1999;258:470-5.
7. Bessen RA, Kocisko DA, Raymond GJ, et al. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 1995;375:698-700.
8. Bossers A, Belt PBGM, Raymond GJ, et al. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. Proc Natl Acad Sci USA 1997;94:4931-6.
9. Bossers A, de Vries R, Smits MA. Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP. J Virol 2000;74: 1407-14.
10. Kocisko DA, Priola SA, Raymond GJ, et al. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc Natl Acad Sci USA 1995;92:3923-7.
11. Raymond GJ, Hope J, Kocisko DA, et al. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 1997;388:285-8.
12. Raymond GJ, Bossers A, Raymond LD, et al. Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. EMBO J 2000; 19:4425-30.
13. Kimberlin RH, Walker CA, Millson GC. Letter: interspecies transmission of scrapie-like diseases. Lancet 1975;2:1309-10.
14. Hegde RS, Mastrianni JA, Scott MR, et al. A transmembrane form of the prion protein in neurodegenerative disease. Science 1998;279:827-34.
15. Stewart RS, Harris DA. Most pathogenic mutations do not alter the membrane topology of the prion protein. J Biol Chem 2001;276:2212-20.
16. Lehmann S, Harris DA. Mutant and infectious prion proteins display common biochemical properties in cultured cells. J Biol Chem 1996;271:1633-7.
17. Prusiner SB. Molecular biology of prion diseases. Science 1991;252:1515-22.
18. Come JH, Fraser PE, Lansbury PT. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 1993;90:5959-63.
19. Jarrett JT, Lansbury PT Jr. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993;73:1055-8.
20. Caughey B, Kocisko DA, Raymond GJ, et al. Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem Biol 1995;2:807-17.
21. Caughey B, Raymond GJ, Kocisko DA, et al. Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. J Virol 1997;71:4107-10.
22. Gajdusek DC. Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to beta-pleated sheet configurations. J Neuroimmunol 1988;20:95-110.
23. Kocisko DA, Lansbury PT Jr, Caughey B. Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain. Biochem 1996;35:13434-42.
24. Lansbury PT Jr, Caughey B. The chemistry of scrapie infection: implications of the "ice 9" metaphor. Chem Biol 1995;2:1-5.
25. Kaneko K, Peretz D, Pan KM, et al. Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform. Proc Natl Acad Sci USA 1995;92: 11160-11164.
26. McKinley MP, Meyer RK, Kenaga L, et al. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol 1991;65:1340-51.
27. Harris DA. Cellular biology of prion diseases. Clin Microbiol Rev 1999;12:429-44.
28. Naslavsky N, Shmeeda H, Friedlander G, et al. Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions. J Biol Chem 1999;274:20763-71.
29. Baron GS, Wehrly K, Dorward DW, et al. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J 2002;21:1031-40.
30. Brimacombe DB, Bennett AD, Wusteman FS, et al. Characterization and polyanion-binding properties of purified recombinant prion protein. Biochem J 1999;342(Pt 3):605-13.
31. Caughey B, Ernst D, Race RE. Congo red inhibition of scrapie agent replication. J Virol 1993;67:6270-2.
32. Naslavsky N, Stein R, Yanai A, et al. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem 1997;272:6324-31.
33. Snow AD, Kisilevsky R, Willmer J, et al. Sulfated glycosaminoglycans in amyloid plaques of prion diseases. 1989;77:337-42.
34. Telling GC, Scott M, Mastrianni J, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995;83:79-90.
35. DebBurman SK, Raymond GJ, Caughey B, et al. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci USA 1997;94:13938-43.
36. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001;24:519-50.
37. Wadsworth JD, Hill AF, Joiner S, et al. Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1999;1:55-9.
38. Butler DA, Scott MR, Bockman JM, et al. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol 1988;62:1558-64.
39. Race RE, Caughey B, Graham K, et al. Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J Virol 1988;62:2845-9.
40. Race RE, Fadness LH, Chesebro B. Characterization of scrapie infection in mouse neuroblastoma cells. J Gen Virol 1987;68(Pt 5):1391-9.
41. Nishida N, Harris DA, Vilette D, et al. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol 2000;74:320-5.
42. Priola SA, Caughey B, Race RE, et al. Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol 1994;68:4873-8.
43. Borchelt DR, Scott M, Taraboulos A, et al. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 1990;110:743-52.
44. Caughey B, Race RE, Vogel M, et al. In vitro expression in eukaryotic cells of a prion protein gene cloned from scrapie-infected mouse brain. Proc Natl Acad Sci USA 1988;85: 4657-4661.
45. Caughey B, Raymond GJ. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 1991; 266:18217-23.
46. Caughey B. Cellular metabolism of normal and scrapie-associated forms of PrP. Semin Virol 1991;2:189-96.
47. Caughey B, Raymond GJ, Ernst D, et al. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 1991;65:6597-603.
48. Head MW, Ironside JW. Inhibition of prion-protein conversion: a therapeutic tool? Trends Microbiol 2000;8:6-8.
49. Priola SA. Prion protein and species barriers in the transmissible spongiform encephalopathies. Biomed Pharmacother 1999;53:27-33.
50. Holscher C, Delius H, Burkle A. Overexpression of nonconvertible PrPc delta 114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild- type PrP(Sc) accumulation. J Virol 1998;72:1153-9.
51. Taraboulos A, Serban D, Prusiner SB. Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J Cell Biol 1990;110:2117-32.
52. Rubenstein R, Carp RI, Callahan SM. In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J Gen Virol 1984;65(Pt 12):2191-8.
53. Schatzl HM, Laszlo L, Holtzman DM, et al. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol 1997;71:8821-31.
54. Horiuchi M, Caughey B. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J 1999; 8:3193-203.
55. Horiuchi M, Priola SA, Chabry J, et al. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. Proc Natl Acad Sci USA 2000;97:5836-41.
56. Caughey WS, Raymond LD, Horiuchi M, et al. Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proc Natl Acad Sci USA 1998; 95:12117-22.
57. Chabry J, Caughey B, Chesebro B. Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J Biol Chem 1998;273:13203-7.
58. Chabry J, Priola SA, Wehrly K, et al. Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence. J Virol 1999; 73:6245-50.
59. Demaimay R, Chesebro B, Caughey B. Inhibition of formation of protease-resistant prion protein by trypan blue, sirius red and other Congo red analogs. Arch Virol 2000; (Suppl 16):277-83.
60. Hill AF, Antoniou M, Collinge J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 1999;80(Pt 1):11-4.
61. Safar J, Cohen FE, Prusiner SB. Quantitative traits of prion strains are enciphered in the conformation of the prion protein. Arch Virol 2000;(Suppl):227-35.
62. Safar J, Wille H, Itri V, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998;4:1157-65.
63. Peretz D, Scott MR, Groth D, et al. Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 2001;10:854-63.
64. Caughey B, Raymond GJ, Bessen RA. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem 1998;273:32230-5.
65. Bessen RA, Marsh RF. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 1992;66: 2096-101.
66. Bessen RA, Marsh RF. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 1994;68:7859-68.
67. Foster JD, Dickinson AG. The unusual properties of CH1641, a sheep-passaged isolate of scrapie. Vet Rec 1988;123:5-8.
68. Pattison IH. The relative susceptibility of sheep, goats and mice to two types of the goat scrapie agent. Res Vet Sci 1966;7:207-12.
69. Carlson GA, Westaway D, DeArmond SJ, et al. Primary structure of prion protein may modify scrapie isolate properties. Proc Natl Acad Sci USA 1989;86:7475-9.
70. Goldmann W, Hunter N, Smith G, et al. PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J Gen Virol 1994;75:989-95.
71. Priola SA, Chabry J, Chan K. Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155. J Virol 2001;75:4673-80.
72. Priola SA, Caughey B, Raymond GJ, et al. Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells. Infect Agents Dis 1994;3:54-8.
73. Priola SA, Caughey B, Wehrly K, et al. A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP. J Biol Chem 1995;270: 3299-3305.
74. Scott MR, Köhler R, Foster D, et al. Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci 1992;1:986-97.
75. Telling GC, Scott M, Hsiao KK, et al. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci USA 1994;91:9936-40.
76. Priola SA, Chesebro B. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J Virol 1995;69:7754-8.
77. Young M, Kirshenbaum K, Dill KA, et al. Predicting conformational switches in proteins. Protein Sci 1999;8:1752-64.
78. Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992;258:806-8.
79. Collinge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991;337:1441-2.
80. Palmer MS, Dryden AJ, Hughes JT, et al. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991;352:340-2.
81. Collinge J, Beck J, Campbell T, et al. Prion protein gene analysis in new variant cases of Creutzfeldt-Jakob disease. Lancet 1996;348:56.
82. Belt PB, Muileman IH, Schreuder BE, et al. Identification of five allelic variants of the sheep PrP gene and their association with natural scrapie. J Gen Virol 1995;76: 509-17.
83. Belt PBGM, Bossers A, Schreuder BEC, et al. PrP allelic variants associated with natural scrapie. In: Gibbs CJ Jr, editor. Bovine spongiform encephalopathy; the BSE dilemma. New York: Springer; 1996. p. 294-305.
84. Bossers A, Schreuder BE, Muileman IH, et al. PrP genotype contributes to determining survival times of sheep with natural scrapie. J Gen Virol 1996;77:2669-73.
85. Goldmann W, Hunter N, Benson G, et al. Different scrapie-associated fibril proteins (PrP) are encoded by lines of sheep selected for different alleles of the Sip gene. J Gen Virol 1991;72:2411-7.
86. Goldmann W, Hunter N, Foster JD, et al. Two alleles of a neural protein gene linked to scrapie in sheep. Proc Natl Acad Sci USA 1990;87:2476-80.
87. Hunter N, Foster JD, Goldmann W, et al. Natural scrapie in a closed flock of Cheviot sheep occurs only in specific PrP genotypes. Arch Virol 1996;141:809-24.
88. Laplanche JL, Chatelain J, Westaway D, et al. PrP polymorphisms associated with natural scrapie discovered by denaturing gradient gel electrophoresis. Genomics 1993;15:30-7.
89. Clouscard C, Beaudry P, Elsen JM, et al. Different allelic effects of the codons 136 and 171 of the prion protein gene in sheep with natural scrapie. J Gen Virol 1995;76: 2097-2101.
90. Hunter N, Goldmann W, Smith G, et al. The association of a codon 136 PrP gene variant with the occurrence of natural scrapie. Arch Virol 1994;137:171-7.
91. Westaway D, Zuliani V, Cooper CM, et al. Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes Dev 1994; 8:959-69.
92. Rezaei H, Choiset Y, Eghiaian F, et al. Amyloidogenic unfolding intermediates differentiate sheep prion protein variants. J Mol Biol 2002;322:799.
93. Soto C, Kascsak RJ, Saborio GP, et al. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet 2000;355:192-7.
94. Horiuchi M, Baron GS, Xiong LW, et al. Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain. J Biol Chem 2001;276:15489-97.
95. Ladogana A, Casaccia P, Ingrosso L, et al. Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J Gen Virol 1992;73(Pt 3):661-5.
96. Supattapone S, Wille H, Uyechi L, et al. Branched polyamines cure prion-infected neuroblastoma cells. J Virol 2001;75:3453-61.
97. Priola SA, Raines A, Caughey WS. Porphyrin and phthalocyanine antiscrapie compounds. Science 2000;287:1503-6.
98. Doh-Ura K, Iwaki T, Caughey B. Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol 2000;74: 4894-7.
99. Lloyd SE, Onwuazor ON, Beck JA, et al. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci USA 2001; 98:6279-83.
100. Kretzschmar HA, Sethi S, Lipford G, Wagner H. Post exposure prophylaxis against prion disease in mice using a stimulator of innate immunity. Plenary presentation at the International Conference of Transmissible Spongiform Encephalopathies, Edinburgh, September 2002.
101. Metz RA. Hope for production of TSE-free herds for organs and sera. Presentation at the Cambridge Healthtech Institues meeting on transmissible Spongiform Encephalopathies, Washington D.C. USA, October 1999.